ORMP
NASDAQ · Pharmaceuticals
Oramed Pharmaceuticals Inc
$3.50
+0.08 (+2.34%)
Open$3.45
Previous Close$3.42
Day High$3.52
Day Low$3.37
52W High$3.76
52W Low$1.82
Volume—
Avg Volume126.0K
Market Cap142.09M
P/E Ratio3.24
EPS$1.01
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+172.9% upside
Current
$3.50
$3.50
Target
$9.55
$9.55
$5.95
$9.55 avg
$10.69
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 32.69M | 32.28M | 32.90M |
| Net Income | 6.94M | 5.51M | 7.09M |
| Profit Margin | 21.2% | 17.1% | 21.6% |
| EBITDA | 9.65M | 8.62M | 9.08M |
| Free Cash Flow | 3.16M | 3.23M | 4.24M |
| Rev Growth | +22.5% | +15.3% | -1.3% |
| Debt/Equity | 0.15 | 0.19 | 0.16 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |